EPA:ALINS - Euronext Paris - Matif - FR0011179886 - Common Stock - Currency: EUR
EPA:ALINS (3/7/2025, 7:00:00 PM)
0.247
+0 (+0.82%)
The current stock price of ALINS.PA is 0.247 EUR. In the past month the price decreased by -5.36%. In the past year, price decreased by -17.94%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEE.DE | VEEVA SYSTEMS INC-CLASS A | 36.31 | 35.90B | ||
COP.DE | COMPUGROUP MEDICAL SE & CO K | 47.08 | 1.21B | ||
NXU.DE | NEXUS AG | 38.83 | 1.20B | ||
EQS.PA | EQUASENS | 13.71 | 577.98M | ||
CONTX.OL | CONTEXTVISION AB | 21.03 | 471.96M | ||
GPI.MI | GPI SPA | 2.75 | 253.54M | ||
CGM.PA | CEGEDIM SA | 89.33 | 188.94M | ||
AGFB.BR | AGFA-GEVAERT NV | N/A | 126.18M | ||
ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 51.69M | ||
AJ91.DE | DOCCHECK AG | 21.04 | 51.21M | ||
M3V.DE | MEVIS MEDICAL SOLUTIONS AG | N/A | 45.86M |
Intrasense SA engages in the design and development of advanced software solutions for viewing and analyzing of medical images. The company is headquartered in Montpellier, Occitanie and currently employs 74 full-time employees. The company went IPO on 2012-02-22. The Company’s activities are divided into three divisions: sales of software for viewing and analyzing medical images; development of peripheral solutions;and supply of services. Its product portfolio comprises the Myrian line products are integrated into existing medical devices, such as Cr, Ultra sound and Nuclear imagining. Myrian Solutions are used for reconstruction of images from the Computed tomography(CT) scan, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography scans, marketed under Myrian brand. The peripheral solutions provide materials for viewing digital images in the operating room, as well as various equipment, including printing servers and workstations, among others. The company offers also support, maintenance, as well as software rental and installation services for its products.
INTRASENSE SAS
1231 Avenue du Mondial 98
Montpellier OCCITANIE FR
Employees: 74
Company Website: https://intrasense.fr/
Investor Relations: https://www.intrasense.fr/investors/
Phone: 33467130130
The current stock price of ALINS.PA is 0.247 EUR. The price increased by 0.82% in the last trading session.
The exchange symbol of INTRASENSE SAS is ALINS and it is listed on the Euronext Paris - Matif exchange.
ALINS.PA stock is listed on the Euronext Paris - Matif exchange.
7 analysts have analysed ALINS.PA and the average price target is 0.24 EUR. This implies a price decrease of -0.89% is expected in the next year compared to the current price of 0.247. Check the INTRASENSE SAS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
INTRASENSE SAS (ALINS.PA) has a market capitalization of 13.02M EUR. This makes ALINS.PA a Nano Cap stock.
INTRASENSE SAS (ALINS.PA) currently has 74 employees.
INTRASENSE SAS (ALINS.PA) has a support level at 0.25 and a resistance level at 0.25. Check the full technical report for a detailed analysis of ALINS.PA support and resistance levels.
The Revenue of INTRASENSE SAS (ALINS.PA) is expected to decline by -29.35% in the next year. Check the estimates tab for more information on the ALINS.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALINS.PA does not pay a dividend.
INTRASENSE SAS (ALINS.PA) will report earnings on 2025-03-25.
INTRASENSE SAS (ALINS.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.08).
ChartMill assigns a technical rating of 1 / 10 to ALINS.PA. When comparing the yearly performance of all stocks, ALINS.PA is a bad performer in the overall market: 91.15% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to ALINS.PA. Both the profitability and financial health of ALINS.PA have multiple concerns.
Over the last trailing twelve months ALINS.PA reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 6.82% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -45.46% | ||
ROE | -73.59% | ||
Debt/Equity | 0.19 |
ChartMill assigns a Buy % Consensus number of 40% to ALINS.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.